Insider Transactions in Q1 2021 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2021
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.88%
|
$487,500
$39.58 P/Share
|
|
Mar 15
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.25%
|
$133,000
$38.82 P/Share
|
|
Mar 05
2021
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.58%
|
$40,000
$2.08 P/Share
|
|
Feb 16
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.25%
|
$115,500
$33.01 P/Share
|
|
Jan 14
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.37%
|
$91,000
$26.71 P/Share
|